Imaging patterns of Pneumocystis jirovecii pneumonia in HIV-positive and renal transplant patients - a multicentre study. by Christe, Andreas et al.
Original article | Published 3 October 2019 | doi:10.4414/smw.2019-20130
Cite this as: Swiss Med Wkly. 2019;149:w20130
Imaging patterns of Pneumocystis jirovecii
pneumonia in HIV-positive and renal transplant
patients – a multicentre study
Christe Andreasa, Walti Laurab, Charimo Jaleda, Rauch Andrib, Furrer Hansjakobb, Meyer Andreasc, Huynh-Do Uyenc,
Heverhagen Johannes Ta, Mueller Nicolas J.d, Cavassini Matthiase, Mombelli Matteoe, van Delden Christianf, Frauenfelder
Thomasg, Montet Xavierh, Beigelman-Aubry Catherinei, Arampatzis Spyridonc*, Ebner Lukasa*, Swiss Transplant Cohort
Study1 and Swiss HIV Cohort Study2
a Department of Diagnostic, Interventional and Paediatric Radiology, Inselspital, Bern University Hospital, University of Bern, Switzerland
b Department of Infectious Diseases, Inselspital, Bern University Hospital, University of Bern, Switzerland
c Department of Nephrology and Hypertension, Inselspital, Bern University Hospital, University of Bern, Switzerland
d Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Switzerland
e Infectious Disease Service, Lausanne University Hospital, Lausanne, Switzerland
f Department of Internal Medicine, Geneva University Hospitals and University of Geneva, Switzerland
g Institute of Diagnostic and Interventional Radiology, University Hospital Zurich, Switzerland
h Division of Radiology, Geneva University Hospitals and University of Geneva, Switzerland
i Radiodiagnostic and Interventional Radiology, CHUV University Hospital, Lausanne, Switzerland
1 Members of the Swiss Transplant Cohort Study: Patrizia Amico, John-David Aubert, Vanessa Banz, Guido Beldi, Christian Benden, Christoph Berger, Isabelle
Binet, Pierre-Yves Bochud, Sanda Branca, Heiner Bucher, Thierry Carell, Emmanuelle Catana, Yves Chalandon, Sabina de Geest, Olivier de Rougemont,
Michael Dickenmann, Michel Duchosal, Laure Elkrief, Thomas Fehr, Sylvie Ferrari-Lacraz, Christian Garzoni, Paola Gasche Soccal, Christophe Gaudet,
Emiliano Giostra, Déla Golshayan, Karine Hadaya, Jörg Halter, Dimitri Hauri, Dominik Heim, Christoph Hess, Sven Hillinger, Hans H. Hirsch, Günther Hof-
bauer, Uyen Huynh-Do, Franz Immer, Richard Klaghofer, Michael Koller (Head of the data center), Bettina Laesser, Guido Laube, Roger Lehmann, Christian
Lovis, Pietro Majno; Oriol Manuel, Hans-Peter Marti, Pierre Yves Martin, Michele Martinelli, Pascal Meylan, (Head, Biological samples management group),
Nicolas J Mueller (Chairman Scientific Committee), Antonia Müller, Thomas Müller, Beat Müllhaupt, Mirjam Naegeli, Manuel Pascual (Executive office), Jakob
Passweg, Klara Posfay-Barbe, Juliane Rick, Eddy Roosnek, Anne Rosselet, Silvia Rothlin, Frank Ruschitzka, Urs Schanz, Stefan Schaub, Aurelia Schnyder,
Christian Seiler, Jan Sprachta; Susanne Stampf, Jürg Steiger (Head, Executive Office), Guido Stirnimann, Christian Toso, Christian Van Delden (Executive
office), Jean-Pierre Venetz, Jean Villard, Madeleine Wick (STCS coordinator), Markus Wilhelm, Patrick Yerly.
2 Members of the Swiss HIV Cohort Study: Aebi-Popp K, Anagnostopoulos A, Battegay M, Bernasconi E, Böni J, Braun DL, Bucher HC, Calmy A, Cavassini
M, Ciuffi A, Dollenmaier G, Egger M, Elzi L, Fehr J, Fellay J, Furrer H, Fux CA, Günthard HF (President of the SHCS), Haerry D (deputy of "Positive Council"),
Hasse B, Hirsch HH, Hoffmann M, Hösli I, Huber M, Kahlert CR (Chairman of the Mother & Child Substudy), Kaiser L, Keiser O, Klimkait T, Kouyos RD, Kovari
H, Ledergerber B, Martinetti G, Martinez de Tejada B, Marzolini C, Metzner KJ, Müller N, Nicca D, Paioni P, Pantaleo G, Perreau M, Rauch A (Chairman of
the Scientific Board), Rudin C, Scherrer AU (Head of Data Centre), Schmid P, Speck R, Stöckle M (Chairman of the Clinical and Laboratory Committee), Tarr
P, Trkola A, Vernazza P, Wandeler G, Weber R, Yerly S.
Summary
OBJECTIVES: To investigate differences in chest com-
puted tomography (CT) and chest radiographs (CXRs) of
Pneumocystis jirovecii pneumonia (PJP) between renal
transplant recipients (RTRs) and human immunodeficien-
cy virus (HIV)-positive patients.
METHODS: From 2005 to 2012, 84 patients with PJP
(RTR n = 24; HIV n = 60) were included in this retrospec-
tive multicentre study. Written informed consent was ob-
tained. CT scans and CXRs were recorded within 2 weeks
after the onset of symptoms. PJP diagnosis was confirmed
either by cytology/histology or successful empirical treat-
ment. Two blinded radiologists analysed the conventional
chest films and CT images, and recorded the radiological
lung parenchyma patterns, lymph node enlargement and
pleural pathologies (pneumothorax, effusion). The radio-
logical features of the two subgroups were compared.
RESULTS: Consolidations and solid nodules prevailed on
CT in RTRs (91.7 ± 5.6% vs 58.3 ± 6.4% with HIV, p
= 0.019 and 91.7 ± 5.6% vs 51.6 ± 6.5% with HIV, p =
0.005). HIV-positive patients with PJP showed more at-
electasis (41.7 ± 6.4% vs 4.2 ± 4.1% in RTRs, p = 0.017)
and hilar lymph node enlargement (23.3 ± 5.5% vs 0.0 ±
0.0% in RTRs, p = 0.088). Ground glass opacification was
found in all cases. Pneumothorax was a rare complication,
occurring in 3% of the HIV-positive patients; no pneumoth-
orax was found in the RTRs. On CXR, the basal lungs
were more affected in HIV-positive patients as compared
with RTRs (p = 0.024).
CONCLUSIONS: PJP on CT differs substantially between
RTRs and HIV-positive patients. Physicians should be
aware of such differences in order not to delay treatment,
particularly in renal transplant recipients.
Keywords: lung, pneumocystis pneumonia, kidney trans-
plantation, HIV, multislice computed tomography
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Introduction
Based on recent studies, diseases of the respiratory tract
still represent a leading cause of morbidity and mortality in
immunocompromised individuals. In particular, pneumo-
nia is a feared complication in solid organ recipients and
human immunodeficiency virus (HIV)-positive patients.
These groups of immunocompromised patients are particu-
larly afflicted by atypical pneumonias due to viral and fun-
gal pathogens, including Pneumocystis jirovecii pneumo-
nia (PJP) [1, 2].
PJP may present with a very variable pattern of clinical and
radiological manifestations, depending on the immunolog-
ical status of the patient. Whereas in HIV-positive individ-
uals the clinical manifestations of PJP are rather subacute
with slow progression, transplanted patients under contin-
ued immunosuppression experience a more aggressive dis-
ease with poor survival rates [3, 4]. Similar to the varying
clinical manifestations, the radiological imaging features
of PJP may exhibit a very broad spectrum of patterns with
predominantly ground glass opacities, septal thickening,
subpleural sparing and cysts [5–7]. A recently published
study showed that the current clinical course of PJP in
immunocompromised patients is rather subtle and rarely
life threatening. In addition, these results suggested that,
compared with renal transplant recipients (RTRs), enlarged
hilar lymph nodes, areas of diffuse infection and ground
glass nodules were a specific radiological imaging feature
of PJP in HIV-positive patients.
The primary aim of the current multicentre, multi-cohort
study was to further explore the computed tomography
(CT) and chest X-ray imaging features of PJP in a suffi-
cient number of immunocompromised patients from two
well-defined cohorts, the Swiss HIV Cohort Study (SHCS)
[8] and RTRs included in the Swiss Transplant Cohort
Study (STCS) [9]. We hypothesised that the imaging pat-
terns on CT differ substantially between HIV patients and
RTRSs.
Material and methods
This multicentre, multi-cohort study was conducted as a
retrospective cross-sectional registry analysis of confirmed
PJP cases retrieved from the SHCS and the STCS. Written
informed consent was obtained according to both cohorts’
registry regulations. Ethical approval from the SHCS and
written informed consent from all participants was ob-
tained. For the RTRs ethical approval from the cantonal
ethic committee of Bern was granted for the retrospective
analysis. From 2005 to 2012, databases of the two national
cohorts were screened for PJP cases. Our cohort includes
data from four university hospitals. The diagnosis of PJP
was established by cytology and/or histology, as well as
clinical responsiveness and radiological resolution under
PJP treatment (trimethoprim/sulfamethoxazole). Concomi-
tant cytomegalovirus infection was excluded by poly-
ABBREVIATIONS:
CT computed tomography
HIV human immunodeficiency virus
PJP Pneumocystis jirovecii pneumonia
RTR renal transplant recipient
merase chain reaction analysis in all patients. According
to the national study registries for HIV patients and solid
organ transplant recipients, a definitive diagnosis was es-
tablished by cytology/microscopy or histology. However, a
presumptive diagnosis of PJP is possible under the follow-
ing conditions:
If on PJP prophylaxis: history of dyspnoea on exertion, or
non-productive cough (within 3 months); typical appear-
ance of diffuse bilateral pulmonary infiltrate, and no bron-
choscopy done or negative bronchoscopy after having re-
ceived at least 1 week of PJP treatment; no evidence of
bacterial pneumonia, and response to PJP treatment.
If not on PJP prophylaxis for at least 2 weeks and CD4
count less than 200: history of dyspnoea on exertion, or
non-productive cough (within 3 months); chest radiograph
normal, atypical or typical for PJP, and no bronchoscopy
done or negative bronchoscopy after having received at
least 1 week of PJP treatment; no evidence of bacterial
pneumonia, and response to PJP treatment.
Additionally, we collected all conventional chest radi-
ographs available within a 2-week period after the onset of
symptoms. After the identification of suitable patients, the
clinical and imaging data at the tertiary care centre were
anonymised and transferred to our institution for further
analysis.
Image acquisition
The CT scans were made on different generations of scan-
ner from various vendors. The scanners comprised 4-, 16-,
64- and 128-row scanners (Siemens, Germany; Philips,
Netherlands, General Electric, USA) applying a slice
thickness of 1 to 2 mm. The scan range was constant, start-
ing at the thoracic inlet and caudally including the whole
lung and adrenal glands. Automated tube current modula-
tion using reference milliampere seconds (mAs) was im-
plemented on the scanners whenever applicable. Addition-
ally, care kilo voltage (kV) was used whenever available.
Chest radiographs were acquired in a prone position and in
two planes (posterior-anterior view and lateral view).
Image interpretation
The read out and pattern annotation was performed by
two subspecialised radiologists in consensus with 6 and 15
years, respectively, of expertise in the field. The radiolo-
gists were informed that the study population consisted of
patients with confirmed pneumocystis pneumonia; howev-
er, the readers were unaware of the underlying condition
(HIV versus renal transplantation).
Prior to the read out, the cases were randomised. The read-
ing was carried out on a standard picture achieving and
communication system (PACS Sectra, Linköping, Swe-
den). All CT scans were reviewed in a standardised lung
stetting with a window level of −600 Hounsfield units
(HU) and a window width of 1600 HU, reconstructed with
a dedicated lung kernel (B/I 70f). For the evaluation of the
soft tissues (the mediastinum), we used a soft tissue ker-
nel reconstruction (B/I 30) in combination with a window
level of 50 HU and a window width of 450 HU. In a sep-
arate reading session, the chest radiographs were analysed.
The readers were unaware of the patients’ underlying dis-
ease as well as the chest CT findings, and the images were
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randomised prior to the read out. The patterns were classi-
fied according to the Fleischner Society glossary of terms
[10]. The following patterns were evaluated by the readers:
consolidation (defined as increased lung density without
contrast enhancement representing infiltration), reticula-
tion, ground glass (diffuse, patchy, mosaic pattern), nod-
ules (solid, subsolid), cysts, signs of fibrosis (honeycomb-
ing), airways (cuffing, mucus plugging, bronchiectasis),
and pleural alterations (thickening, effusion). Furthermore,
the readers evaluated the lymph nodes in the mediastinum
and in the hilar regions. The mediastinal and hilar lymph
nodes were assessed in a soft tissue window; lymph node
enlargement was defined as a short axis diameter ≥1cm.
In total, both radiologists recorded 43 radiographic find-
ings. The distribution of parenchymal changes within the
lung was recorded according to the segmental anatomy of
the lungs (10 segments on the left and 10 segments on the
right). Additionally, we further assessed the disease loca-
tion within the right and left lung: central-perihilar changes
versus peripheral-subpleural changes as well as diffuse af-
fection of the lungs. Parenchymal changes showing a sub-
pleural sparing were recorded separately.
The classification of imaging patterns is described in more
detail in appendix 1.
Statistics
Continuous data were compared using Student’s t test if
normally distributed; otherwise, the Mann-Whitney test
was applied. Statistical analyses of non-continuous di-
chotomous data were compared using the chi-square test
or Fisher’s exact test. The absolute frequency of each lung
pattern was recorded and compared between groups. The
standard error of frequency was assessed. All p-values
were two-sided, and the level of significance was set to
0.05. A post hoc Bonferroni test was applied to evaluate
significant differences between each assessed value. The
five most frequent groups of patterns were corrected by
a factor of five; all other pattern and location variables
were corrected according to the number of variables. Addi-
tionally, a multiple logistic regression model was applied.
The statistical analysis was performed with MedCalc Ver-
sion 7.6.0.0 statistical software (MedCalc Software, Os-
tend, Belgium).
Results
After applying the inclusion criteria, a total of 84 patients
with confirmed PJP were included in this study population.
We identified 24 renal transplant recipients (30%) and 60
HIV patients (70%) with PJP (demographic data are sum-
marised in table 1).
Computed tomography findings
A total of 47 different chest patterns were recorded in the
reading sessions, including pleural alterations and lymph
node enlargement. As compared with HIV, consolidations
and solid nodules (fig. 1) were more frequent in RTRs
(91.7 ± 5.6% vs 58.3 ± 6.4% with HIV, p = 0.019 and 91.7
± 5.6% vs 51.6 ± 6.5% with HIV, p = 0.005, respectively;
table 2). All RTRs had ground glass opacifications, where-
as none had enlarged hilar lymph nodes.
In comparison, the HIV-positive patients with PJP showed
significantly more areas of atelectasis (41.7 ± 6.4%, vs 4.2
± 4.1% in RTRs, p = 0.017; table 2). Furthermore, HIV
patients tended to present with a more “classic” pattern of
PJP, exhibiting subpleural sparing (fig. 2) and additional
hilar lymph node enlargement (23.3 ± 5.5%; fig. 3). Pneu-
mothorax formation was restricted to 3.3% of the HIV-
positive patients. When the results from the conservative
Bonferroni method were compared with the results from a
multi-variable analysis, significantly more cysts could be
found in HIV than in RTR cases (15.0 ± 4.6% vs 4.2 ±
4.1%, p = 0.038; table 2). An analysis of the disease distri-
bution within each lung segment between the two cohorts
did not yield any statistically significant results (table 2).
Chest radiograph findings
The patterns for each chest radiograph were recorded
(table 3). Overall, there were no differences in patterns be-
tween the two cohorts according to the Bonferroni correct-
ed results. However, the results from the logistic regression
model showed that there was a significantly higher preva-
Table 1: Demographic information.
RTR group HIV group
Total N 24 60
Gender (M:F) 15:9 42:18
Median age (years, range) 64 39–70 43 25–76
Median time from transplantation / HIV diagnosis to PJP (days, years, range) 2y (0–11y) 45d (0d–27y)
CD4 count (cl/ml), median (IQR) n/a 79 (3–436)
Underlying disease in RTRs ADPKD 7 29.2% –
IgA-nephropathy 5 20.8% –
Diabetic nephropathy 6 25.0% –
Chronic tubular interstitial nephropathy 3 12.5% –
Focal segmental glomerulosclerosis 2 8.3% –
Mesangioproliferative glomerulonephritis 1 4.2% –
HIV risk group Injection drug user – 7 11.7%
Men who have sex with men – 21 35.0%
High risk heterosexuals – 28 46.7%
Unknown – 4 6.7%
HIV diagnosis made following PJP – 13 21.7%
ADPKD = autosomal dominant polycystic kidney disease; HIV = human immunodeficiency virus; n/a = not applicable; PJP = Pneumocystis jirovecii pneumonia; RTR = renal
transplant recipient
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lence of reticulation in RTRs as compared with HIV pa-
tients (95.7 ± 4.2% vs 86.0 ± 4.5%; table 3). Consolida-
tions and solid nodules were found in 47.8 ± 10.2% and 4.3
± 4.2% of RTRs, respectively. Consolidation and multiple
nodules were more prevalent in the HIV-positive patient
cohort (fig. 4). For the pattern distribution within the lung
lobes, we found that the basal lungs, namely, middle lobe,
lingula and lower lobes, were significantly more affected
in HIV-positive patients (75.0 ± 5.6% vs 58.7 ± 10.1% in
RTRs p = 0.021; fig. 5). In particular, the middle lobe was
mainly involved in the HIV-positive cohort (64.0 ± 6.2%
vs 17.4 ± 7.7% in RTRs, p = 0.006; table 3).
Discussion
The aim of the present study was to investigate the PJP-
related imaging patterns on CT and chest radiography in
Figure 1: Axial computed tomography (CT) image from a renal transplant recipient. Typical CT image findings of a renal transplant recipient:
patchy consolidations are found in the right upper lobe as well as in the apical segment of the left lower lobe (asterisk). There is also diffuse
ground glass opacification present (blue arrow); of note, slight subpleural sparing can be seen in the anterior upper lobes. Solid nodules (red
arrows) are also present in the periphery of the right upper and lower lobe.
Table 2: Pneumocystis jirovecii pneumonia lung patterns and locations on computed tomography.
Pattern RTR (% ± SD) HIV+ (% ± SD) p-value p-value*
Consolidation 91.7 ± 5.6 58.3 ± 6.4 0.018 0.002
Atelectasis 4.2 ± 4.1 41.7 ± 6.4 0.017 0.016
Reticulations 83.3 ± 7.6 66.7 ± 6.1 0.91 0.383
Ground glass Diffuse 66.7 ± 9.6 58.3 ± 6.4 1.00 0.604
Patchy 87.5 ± 6.8 66.7 ± 6.1 0.68 0.062
Mosaic 37.5 ± 9.9 28.3 ± 5.8 1.00 0.413
Ground glass nodules Any 100 ± 0.0 96.7 ± 2.3 1.00 0.432
GGN 75.0 ± 8.8 68.3 ± 6.0 1.00 0.799
Solid 91.6 ± 5.6 51.6 ± 6.5 0.005 0.004
Mixed 12.5 ± 6.8 23.3 ± 5.5 1.00 0.068
Nodules Any 95.8 ± 4.1 76.7 ± 5.5 0.009 0.040
Cysts 4.2 ± 4.1 15.0 ± 4.6 1.00 0.038
Hilar lymph nodes 0.0 ± 0.0 23.3 ± 5.5 0.088 0.984
Mediastinal lymph nodes 33.3 ± 9.6 43.3 ± 6.4 0.466 0.238
Location Central 75 ± 8.8 55 ± 6.4 0.42 0.113
Peripheral 91.7 ± 5.6 75 ± 5.6 0.4 0.689
Multifocal 79.2 ± 8.3 50 ± 6.4 0.047 0.249
Diffuse 66.7 ± 9.6 70 ± 5.9 1.00 0.581
Subpleural sparing 16.7 ± 7.6 51.7 ± 6.5 0.01 0.020
GGN = ground glass nodules; SD = standard deviation Significant results are displayed in bold font * p-values from logistic regression
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HIV-positive and renal transplant patients. Our results in-
dicate that there are distinct radiological patterns on CT
scans, but not on radiographs, within both groups.
The PJP radiological CT findings in renal transplant pa-
tients were dominated by multifocal consolidation and sol-
id nodularities, whereas in the HIV population more clas-
sic subpleural sparing was present. A common feature in
both groups was ground glass opacification, a finding also
previously reported by Tasaka et al. [11] when comparing
PJP features in oncological patients and HIV patients.
Hardak et al. [5] also reported extensive ground glass den-
sities in a mixed patient population with PJP. Ground glass
opacification therefore has a high sensitivity for PJP and
a lack of this feature seems to rule out PJP with a high
level of certainty, irrespective of aetiology of underlying
immunosuppression. The finding of atelectasis is reported
to be infrequent in patients with PJP. However, in the data
presented here, atelectasis was a significant finding in pa-
tients with HIV. It has been reported previously that pa-
tients with HIV and PJP have a larger pneumocystis bur-
den and reduced neutrophil count when compared with
PJP patients without HIV. Although not evaluated in this
study, this might be a factor in the development of atelecta-
sis in these patients. Another contributing factor might be
the presence of excessive foam-like exudate in the alveoli,
which is a considered a typical finding in microscopy. The
foamy exudate in combination with hyaline membrane for-
mation and granulomatous inflammation, also microscopic
findings in PJP, might explain the higher prevalence of at-
electasis in the HIV cohort.
Prevalence of subpleural sparing has frequently been re-
ported in HIV-related PJP cases [12, 13]. This finding was
also evident in the presented data; however, it mainly ap-
plied to HIV patients. In RTRs, subpleural sparing was
found in only a minority of patients. Furthermore, micron-
odules showed a high prevalence in the transplant pop-
ulation, whereas they were exceedingly rare in the HIV
group. Another important finding in this study population
was that hilar lymph node enlargement was exclusively
found in HIV-positive individuals. Previous studies, how-
ever, showed that PJP is rarely associated with lym-
phadenopathy on imaging studies [14]. These diverging
imaging manifestations may reflect the effect of the dif-
ferent aetiology of immunosuppression on the radiological
appearance of PJP [15].
Of note, pulmonary cysts, previously described as a hall-
mark feature in PJP, were present in only 4% of the HIV-
positive patients and in none of the RTRs. With the ad-
vance of prophylaxis in high-risk groups, this classic
complication is now an infrequent finding.
Besides the previously described diffuse lung effects in
HIV patients [10], this multicentre cohort demonstrated al-
so patterns that were multifocally distributed. Additional-
ly, the predominance of ground glass nodules in the RTR
patients could not be confirmed; instead, we found more
solid nodules. Whereas in a previous study, HIV patients
and transplant recipients exhibited subpleural sparing, the
Figure 2: Computed tomography (CT) findings in a human immunodeficiency virus-positive patient suffering from Pneumocystis jirovecii pneu-
monia (PJP) (axial CT section at the level of the lung bases): diffuse ground glass opacity (asterisk) and subpleural sparing (arrows) was
found to represent a more or less classic CT-pattern for PJP.
Original article Swiss Med Wkly. 2019;149:w20130
Swiss Medical Weekly · PDF of the online version · www.smw.ch
Published under the copyright license “Attribution – Non-Commercial – No Derivatives 4.0”.
No commercial reuse without permission. See http://emh.ch/en/services/permissions.html.
Page 5 of 10
recent analysis revealed that this feature was foremost in
HIV-associated cases of PJP [7]. In contrast, both studies
found no enlarged lymph nodes in renal transplant patients.
Differences in the presentation of PJP between HIV and
RTR cases could reflect immunological differences be-
tween HIV- and transplant-associated immunodeficiencies.
For example, the immune system is ceasing in HIV-posi-
tive patients, but is suddenly and continuously suppressed
by therapy in RTR. However, this remains speculative and
we will explore this finding in further studies primarily fo-
cusing on the manifestation pathway.
The most common clinical signs were subtle in both
groups and the duration from illness onset to hospital pre-
sentation was longer in the HIV patients, implying a less
fulminant clinical course. The higher prevalence of atelec-
tasis in HIV patients might reflect the more chronic nature
of PJP in this population. On the other hand, most RTR
PJP cases occurred several months (>12 months) after suc-
cessful transplantation, with no prophylactic treatment at
PCP diagnosis and with a suspected viral upper respiratory
tract infection. Thus, the significant presence of consolida-
tion in RTRs might reflect a concurrent infection with oth-
Figure 3: Axial cross section image in soft tissue window at the level of the carina in a human immunodeficiency virus (HIV)-positive patient
with Pneumocystis jirovecii pneumonia (PJP). There is mediastinal lymph node enlargement at the left and right lower paratracheal nodal sta-
tions (arrows). Although not specific for PJP in HIV-positive individuals, mediastinal lymph node enlargement was more frequent in this patient
population. TR = trachea; SVC = superior vena cava; PA = pulmonary artery; AO = aorta
Table 3: Pneumocystis jirovecii pneumonia patterns on chest radiographs.
Pattern RTR (% ± SD) HIV+ (% ± SD) p-value* p-value†
Opacity Acinar 47.8 ± 10.2 54.0 ± 6.4 1 0.587
Reticulation 95.7 ± 4.2 86.0 ± 4.5 1 0.034
Nodules Solitary 4.3 ± 4.2 2.0 ± 1.8 1 0.820
Multiple 4.3 ± 4.2 12.0 ± 4.2 1 0.247
PJP-specific Cysts 0.0 ± 0.0 8.0 ± 3.5 1 0.983
Subpleural sparing 0.0 ± 0.0 2.0 ± 1.8 1 0.992
Pneumothorax 0.0 ± 0.0 4.0 ± 2.5 1 0.988
Distribution Right upper lobe 56.5 ± 10.1 72.0 ± 5.8 1 0.335
Middle lobe 17.4 ± 7.7 64.0 ± 6.2 1 0.006
Right lower lobe 91.3 ± 5.8 86.0 ± 4.5 1 0.113
Left upper lobe 69.6 ± 9.4 72.0 ± 5.8 1 0.560
Lingula 34.8 ± 9.7 62.0 ± 6.3 1 0.735
Left lower lobe 91.3 ± 5.8 88.0 ± 4.2 1 0.629
Lower lung‡ 58.7 ± 10.1 75.0 ± 5.6 0.021 n/a
Symmetry 69.8 ± 19.0 74.9 ± 26.0 0.86 n/a
HIV = human immunodeficiency virus; PJP = Pneumocystis jirovecii pneumonia; RTR = renal transplant recipient; SD = standard deviation * Bonferroni corrected p-values (factor
15) † p-values from logistic regression ‡ lower lobe + middle lobe / lingula
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er pathogens. In addition, the higher prevalence of small
nodules in RTRs, in combination with ground glass opaci-
fications, most likely represent ongoing or chronic alveoli-
tis.
We found that cystic lung changes were significantly more
frequent in HIV patients. This phenomenon has been en-
countered previously. In fact, the prevalence of cysts in
PJP has declined, presumably owing to prophylactic ther-
apy in high-risk populations. However, there is still a dis-
crepancy between RTR and HIV patients, with the latter
showing more cystic changes. One explanation could be
that a considerable number of these patients show less
compliance with treatment or slower disease progression
than the transplant patients. Another reason might be the
clinical presentation.
Finally, when we look at the time of symptom onset, we
struggle to provide specific data. This is also a clinical
problem, since the symptom onset in RTRs is acute, where-
as in HIV patients we observed a more indolent course
of symptoms. Based on the different clinical presentation,
it is possible that some of the imaging differences may
reflect different time points of investigation. Presumably,
RTRs show the acute manifestation of PJP and imaging
features of PJP in HIV patients represent a subacute to
chronic spectrum of the disease. In this study, several sig-
nificant differences in CT findings between HIV-associ-
ated PJP and renal transplant-associated PJP were found;
however, only a few differences could be defined on chest
radiographs. This reflects the limited capabilities of chest
radiography for the disease characterisation, in particular
in cases of atypical pneumonia.
Analysing the demographic data of both cohorts, we found
a substantial difference in the median time from renal
transplantation and HIV diagnosis to PJP. In the RTR
group, the disease occurred several years after transplan-
tation, when patients were without any chemoprophylaxis
for PJP; in the HIV group, this was only 45 days. However,
both groups showed a substantial time range (0–11 years in
RTRs vs 0–27 years in HIV patients). This might explain
the differences in imaging features. In addition, the pos-
sibility of PJP breakthrough in the RTR cohort may have
played a role in the similar clinical and radiological mani-
festation of the disease.
Our study has some limitations. The sample size is rela-
tively small, especially for a multicentre study design. Sta-
tistically, this issue has been addressed by using a conserv-
ative Bonferroni correction to balance the different cohort
sizes. Furthermore, both cohorts use different definitions
of PJP infection, which could have affected the interpre-
tation. Also, the study population also contained subjects
with non-contrast CT scans, mainly because of limited re-
nal function especially in RTRs. The detection of hilar
lymph nodes on non-contrast CT scans can be challenging
and particular focus should centre on the lymph node as-
Figure 4: Bilateral nodular consolidation in a human immunodeficiency virus -positive patient.
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Figure 5: Faint homogeneous central ground glass opacity with sparing of the caudal lungs/sinus phrenicocostalis (arrows) in a renal trans-
plant patient.
sessment in those cases. Finally, the period between imag-
ing and disease onset of 2 weeks is relatively long and
might have impaired the study results.
In summary, the extension of our study to the national
level based on confirmed PJP cases coming from four ter-
tiary hospitals revealed a rather variable but disease-spe-
cific manifestation pattern of PJP, most likely attributable
to the underlying aetiology of immunosuppression. Indeed,
whereas CD4 cell counts below 200 cell/ml are a clearly
identified risk factor for PJP in the HIV-positive popula-
tion, such an association has not been established in the
transplant population so far, supporting the hypothesis that
the distinct underlying conditions led to different types of
immunosuppression. Based on the differing imaging man-
ifestations of PJP in transplant recipients and HIV-positive
patients, it is of utmost importance for radiologists to be
aware of the spectrum of patterns in the context of different
underlying diseases and to show high awareness in high-
risk groups.
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Appendix 1
Classification of imaging patterns
Summary of recorded imaging patterns: 1 – ground glass
opacity (GGO) (increase in lung attenuation without ob-
scuring pulmonary vessels), 2 – mosaic ground glass opac-
ity (alternating GGO adjacent to hypoattenuating lung with
sharp demarcation), 3 – ground glass nodule (GGN, nodule
with ground-glass density), 4 – mixed nodule (mixN, nod-
ule with a solid center and peripheral halo of GGO with
a minimal width of 1 mm), 5 – smooth, solid nodule (N,
well-demarcated dense nodule), 6 – lobulated, solid nodule
(IN, convex outpouchings), 7 – spiculated, solid nodule
(sN, linear radiations extending from the nodule), 8 – cav-
itary nodule (cN, presence of gas in the nodule), 9 – oval
nodule (oN), 10 – calcified nodule (Ca++N, nodule with
a density greater than 200 HU), 11 – tree-in-bud (well-
defined pulmonary nodules with centrilobular branching
opacities), and 12 – centrilobular nodules (cluster of small,
peribronchovascular nodules). Furthermore, interstitial
lung densities were classified as follows: 13 – reticulation
(fine reticular grid and thickened interlobular septa), 14
– linear opacities (linear densities of > 1 mm thickness),
15 – coarse reticulation (thick reticular grid), 16 – beaded
septum sign (nodular thickening of interlobular septa), 17
– honeycombing (peripheral cysts within a coarse retic-
ulation), 18 – bulla (round hypoattenuation >1 cm with
no or thin wall), 18.1 – centrilobular emphysema (cen-
trilobular areas of decreased attenuation, generally without
visible walls), 18.2 – panacinar emphysema (decrease in
lung parenchyma, several adjacent bullae, and no normal
lung in between); 18.3 – paraseptal emphysema (subpleur-
al string of bullae), and 19 – cyst (round hypoattenuation
with a thin wall < 2 mm).
Air-space disease was classified as follows: 20 – air-space
disease (AS, dense acinar consolidation) and 20.1 – air-
space disease with positive bronchogram (consolidation
with branching hyperlucencies). Pleural disease was di-
vided into the following patterns: 21 – pleural thickening
(pleura > 1 mm thick), 21.1 – pleural thickening with ad-
jacent reticulation, 22 – nodular pleural thickening (< 10
mm), 22.1 – nodular pleural thickening (> 10 mm), 23 –
pleural plaque (rectangular pleural thickening), 24 – pleur-
al scar (pleural thickening > 10 mm), 25 – pleural effusion,
and 25.1 – loculated effusion.
Finally, airway diseases were classified with the following
patterns: 26 - bronchial cuffing (diffuse thickening of the
bronchial wall), 27 – focal bronchial thickening (segmental
thickening of the bronchial wall), 28 - bronchial secretion
(hypoattenuating bronchial fluid), 29 – mucus plugging
(dense content in segmental dilated bronchus), 30 –
bronchiectasis (bronchus with a larger diameter than the
accompanying artery), 31 – (sub-)segmental volume loss
(small lung segments with a concentration of vessels), and
32 – segmental air trapping (hypoattenuating lobule with
separated vessels). In addition, the radiologists recorded
the presence of pleural effusions and hilar and mediastinal
lymphadenopathies (node > 1 cm). Furthermore, the distri-
bution of the parenchymal changes within the lung (seg-
mental and central versus subpleural distribution) was not-
ed [7].
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